|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 17, 2017 ) According to Publisher, the Global Genome Editing market is estimated at $1,165.76 billion in 2015 and is expected to reach $1,692.30 billion by 2022 growing at a CAGR of 5.5% from 2015 to 2022. Improving standard of living and increase in disposable incomes are the factors fueling the market growth. Technological convergence is hampering the Genome Editing market. Hand held devices segment which consist of devices like mobile phones and portable play stations accounted the largest market share. Audio/Video segment is expected to grow at highest CAGR during forecast period.
North America captured huge market share owing to the increase in biotechnology and pharmaceutical industries in United States. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of rapid increase in research and development this region. Pharmaceutical and Biotechnology Companies in end user segment holds largest share in the market.
For more information @ http://www.reportsweb.com/genome-editing-global-market-outlook-2016-2022
Some of the key players in the market are Sangamo Biosciences, Inc., Origene Technologies, Inc., MERCK KGAA, Thermo Fisher Scientific, Inc., New England Biolabs, Inc., CELLECTIS S.A., Horizon Discovery Group Plc, Lonza Group Ltd., APPLIED STEMCELL INC., Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc and Genscript USA Inc.
Products And Services Covered:
- Genome Editing Services
- Software
- Reagents, Enzymes and Consumables
o Delivery Tools
o Genome Editing Tools And Kits
o Other Reagents, Enzymes And Consumables
- Instruments
- Cell Lines and Animal Models
Technologies Covered:
- Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
o Crispr Dcas9
o Wt Crispr/Cas9
o Crispr/Cas9 Nickase
- Transcription Activator-Like Effector Nucleases (Talen)
- Zinc Finger Nuclease (Zfn)
- Antisense Technology
- Other Technologies
o Arcus (Homing Endonuclease) And Megatal
o Recombinant Adeno-Associated Virus (R Aav)
o Targatt And Rapid Trait Development System (Rtds)
o Piggybac Transposase And Sleeping Beauty Transposon
Applications Covered:
- Plant Biotechnology/Agriculture
- Drug Discovery and Development
o Clinical
o Pre-Clinical
- Basic Research
o Genomic Visualization
o Genomic Screening
o Transcription Activation/Repression
- Animal Biotechnology
o Livestock
o Animal Health
o Other Animal Biotechnology
- Cell Line Engineering
End Users Covered:
- Pharmaceutical And Biotechnology Companies
- Academic And Government Research Institutes
- Plant Biotechnology Companies
- Others End Users
o Contract Research Organizations (Cro)
o Animal Biotechnology
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001565012/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001565012/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
